Adagio Medical Holdings, Inc. is a medical device company, which engages in the development and placing on the EU market innovative ablation technologies for the treatment of cardiac arrhythmias, including atrial fibrillation, atrial flutter, and ventricular tachycardia. The company was founded on August 24, 2020 and is headquartered in New York, NY.